CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 53 filers reported holding CYTOSORBENTS CORP in Q3 2023. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,446 | +52565.8% | 20,450 | 0.0% | 0.04% | -22.8% |
| Q2 2023 | $73 | +12.3% | 20,450 | 0.0% | 0.06% | +16.3% |
| Q1 2023 | $65 | +103.1% | 20,450 | 0.0% | 0.05% | +104.2% |
| Q4 2022 | $32 | -99.9% | 20,450 | -14.4% | 0.02% | -7.7% |
| Q3 2022 | $33,000 | -36.5% | 23,900 | 0.0% | 0.03% | -33.3% |
| Q2 2022 | $52,000 | -31.6% | 23,900 | 0.0% | 0.04% | -13.3% |
| Q1 2022 | $76,000 | -24.0% | 23,900 | 0.0% | 0.04% | -16.7% |
| Q4 2021 | $100,000 | -47.4% | 23,900 | +2.1% | 0.05% | -51.4% |
| Q3 2021 | $190,000 | +9.8% | 23,400 | +2.2% | 0.11% | +9.9% |
| Q2 2021 | $173,000 | -16.4% | 22,900 | -4.2% | 0.10% | -24.1% |
| Q1 2021 | $207,000 | +14.4% | 23,900 | +5.3% | 0.13% | +1.5% |
| Q4 2020 | $181,000 | +13.1% | 22,700 | +13.5% | 0.13% | +1.6% |
| Q3 2020 | $160,000 | – | 20,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 675,000 | $918,000 | 1.02% |
| Sargent Investment Group, LLC | 1,108,233 | $2,028,000 | 0.63% |
| Skylands Capital, LLC | 2,347,034 | $3,192,000 | 0.52% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 253,000 | $344,000 | 0.37% |
| Avenir Corp | 2,314,854 | $3,148,000 | 0.33% |
| Granahan Investment Management | 1,511,029 | $2,055,000 | 0.07% |
| ACT CAPITAL MANAGEMENT, LLC | 35,000 | $48,000 | 0.07% |
| Winning Points Advisors, LLC | 22,900 | $33,000 | 0.04% |
| Cowen Prime Advisors LLC | 42,200 | $57,000 | 0.03% |
| Seelaus Asset Management LLC | 23,900 | $33,000 | 0.03% |